The SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation

• Authors: Alexandra Herrmann, Friedrich-Alexander University Erlangen-Nürnberg; Sabine Wittmann, Friedrich-Alexander University Erlangen-Nürnberg; Dominique Thomas, Goethe-University; Caitlin Shepard, Emory University; Baek Kim, Emory University; Nerea Ferreiros, Goethe-University; Thomas Gramberg, Friedrich-Alexander University Erlangen-Nürnberg
• Journal Title: Mobile DNA
• Volume: Volume 9, Number 1
• Publisher: BMC (part of Springer Nature) | 2018-03-28, Pages 11-11
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1186/s13100-018-0116-5
• Subjects: Health Sciences, General
• Keywords: Science & Technology; Life Sciences & Biomedicine; Genetics & Heredity; LINE-1; SAMHD1; Endogenous retroelements; Restriction factor; Aicardi-Goutieres syndrome; Intrinsic immunity; AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; ACID BINDING-PROTEIN; HIV-1 RESTRICTION; REVERSE-TRANSCRIPTASE; RIBONUCLEASE-ACTIVITY; NUCLEASE ACTIVITY; DNTPASE ACTIVITY; MAMMALIAN-CELLS; RETROTRANSPOSITION

Abstract

Background: The restriction factor SAMHD1 regulates intracellular nucleotide level by degrading dNTPs and blocks the replication of retroviruses and DNA viruses in non-cycling cells, like macrophages or dendritic cells. In patients, inactivating mutations in samhd1 are associated with the autoimmune disease Aicardi-Goutières Syndrome (AGS). The accumulation of intracellular nucleic acids derived from endogenous retroelements thriving in the absence of SAMHD1 has been discussed as potential trigger of the autoimmune reaction. In vitro, SAMHD1 has been found to restrict endogenous retroelements, like LINE-1 elements (L1). The mechanism, however, by which SAMHD1 blocks endogenous retroelements, is still unclear. Results: Here, we show that SAMHD1 inhibits the replication of L1 and other endogenous retroelements in cycling cells. By applying GFP- and neomycin-based reporter assays we found that the anti-L1 activity of SAMHD1 is regulated by phosphorylation at threonine 592 (T592). Similar to the block of HIV, the cofactor binding site and the enzymatic active HD domain of SAMHD1 proofed to be essential for restriction of L1 elements. However, phosphorylation at T592 did not correlate with the dNTP hydrolase activity of SAMHD1 in cycling 293T cells suggesting an alternative mechanism of regulation. Interestingly, we found that SAMHD1 binds to ORF2 protein of L1 and that this interaction is regulated by T592 phosphorylation. Together with the finding that the block is also active in cycling cells, our results suggest that the SAMHD1-mediated inhibition of L1 is similar but not identical to HIV restriction. Conclusion: Our findings show conclusively that SAMHD1 restricts the replication of endogenous retroelements in vitro. The results suggest that SAMHD1 is important for maintaining genome integrity and support the idea of an enhanced replication of endogenous retroelements in the absence of SAMHD1 in vivo, potentially triggering autoimmune diseases like AGS. Our analysis also contributes to the better understanding of the activities of SAMHD1 in antiviral defense and nucleotide metabolism. The finding that the phosphorylation of SAMHD1 at T592 regulates its activity against retroelements but not necessarily intracellular dNTP level suggests that the dNTP hydrolase activity might not be the only function of SAMHD1 important for its antiviral activity and for controlling autoimmunity.